BRANFORD, Conn., March 23, 2009 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NasdaqGM:CASM - News) today announced the FDA 510(k) clearance of its Medium (Pediatric) Sensor for use with the Company’s FORE-SIGHT(r) Absolute Cerebral Oximeter. The Medium Sensor is the latest in the FORE-SIGHT family of absolute cerebral oximeter sensors. This new product is indicated for use on patients weighing between 4kg and 80kg. CASMED plans a limited release of the Medium Sensor in April to select customers, with full commercial release scheduled for the end of Q2.
Along with the original Large (Adult) Sensor and the Small (Neonatal/Infant) Sensor released last year, the FORE-SIGHT sensor line now covers the full range of patient populations in the hospital. The target markets for the Medium Sensor are in the areas of pediatric intensive care, pediatric cardiovascular OR and cardiovascular intensive care. In the U.S. there are 3,800 pediatric intensive care beds and over 200,000 patients per year.
The limited release of the FORE-SIGHT Medium Sensor will allow selected hospitals to be the first to use the full family of sensors with the unique FORE-SIGHT Absolute Cerebral Oximeter. ``We are looking forward to working closely with our first customers to implement the use of the new Medium Sensor,’' stated Andrew E. Kersey, President and CEO of CASMED. ``With the release of the Medium Sensor, we are able to meet hospitals’ needs for a complete line of sensors for accurate, reliable absolute cerebral oximetry readings.’'
About CASMED(r) - Monitoring What’s Vital
CAS Medical Systems, Inc. is a leading developer and manufacturer of medical devices for non-invasive patient monitoring. The Company’s FORE-SIGHT Absolute Cerebral Oximeter is the only cerebral oximeter available with FDA clearance for non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation for neonates, infants, children and adults. This information helps avert brain damage or death during surgery and in critical care situations by allowing clinicians to identify patients with dangerously low levels of cerebral oxygen and intervene to reverse the condition.
The Company’s product lines include the critical care monitoring capabilities of the FORE-SIGHT Cerebral Oximeter, the bedside patient monitoring line of vital signs and cardio-respiratory monitoring products, proprietary non-invasive blood pressure measurement technology, and supplies and service including blood pressure cuffs and products for neonatal intensive care. CASMED products are designed to meet the needs of a full spectrum of patient populations worldwide, ranging from adults to pediatrics and neonates.
The CAS Medical Systems, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4675
For further information regarding CAS Medical Systems, Inc., visit the Company’s website at http://www.casmed.com.
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future financial performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, commercialization and technological difficulties, the impact of actions and events involving key customers and vendors, and other risks detailed in the Company’s Form 10-K for the year ended December 31, 2007 and other subsequent Securities and Exchange Commission filings.
Such statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release the terms ``anticipate’’, ``believe’’, ``estimate’’, ``expect’’, ``may’’, ``objective’’, ``plan’’, ``possible’’, ``potential’’, ``project’’, ``will’’ and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information or otherwise. Contact:
CAS Medical Systems, Inc. Susan Carron, Director of Corporate Communications 203-488-6056 ir@casmed.com
